TREX1 and Aicardi-Goutieres syndrome: AGS patients also show high levels of type I IFN in the serum and the cerebrospinal fluid [139] because of the mutated TREX1 enzyme, which is not able to prevent intracellular DNA detection by innate immune sensors, thus inducing type I IFN activation and accumulation.